Senior Director, Search & Evaluation Late TA Lead, (He)

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Could you be our next Senior Director Search & Evaluation Late TA Lead, (He)? The job is in our Waltham MA Office. This is a hybrid position and is onsite three days a week.

Position DescriptionSummary

Three Senior/Executive Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas. These leaders will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions.

MainResponsibilities & Accountabilities

• Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.
  
• Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.
  
• Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL's therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations
  
• Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics.
  
• Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.
  
• Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.
  
• Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution
  
• Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.
  

• 15+ years in biopharma with significant experience in clinical development, external innovation, or business development.
  
• Advanced degree required (MD, PhD, or equivalent).
  
• Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas.
  
• Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.
  
• Strong understanding of regulatory pathways, market access, and competitive standards of care.